18 November 2017
News and Views
Links and Services
March's issue of Inflammatory Bowel Disease investigates cancer in Crohn's disease patients treated with infliximab.
The long-term risk of neoplasia in Crohn's disease patients treated with infliximab is undefined.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors